Revenues, Adjusted Earnings and Backlog Increase to Record Highs
BEDFORD, Mass., Jan. 31 /PRNewswire-FirstCall/ -- Hologic, Inc.
(Nasdaq: HOLX), a diversified medical technologies company specializing in
diagnostics, imaging systems and interventional devices dedicated to
serving the healthcare needs of women, today announced its results for the
quarter ended December 29, 2007.
Highlights of the quarter include:
-- Record revenues of $371.4 million.
-- Merger with Cytyc Corporation on October 22, 2007 contributes $158
million of revenue (for 10 of 13 weeks).
-- Record 384 Selenia full field digital mammography systems installed and
recognized as revenue.
-- Record backlog of $244.5 million for historical businesses
(mammography/breast care/skeletal health).
-- Issued $1.725 billion of convertible senior notes (at 2% interest).
-- Term loan balance reduced to $295 million at December 29, 2007.
-- Reported net loss of $358.6 million due primarily to non-cash charges
related to the Cytyc merger.
-- Hologic was added to the Nasdaq-100 index(R) on December 24, 2007.
First quarter fiscal 2008 revenues totaled $371.4 million, a 128%
increase when compared to revenues of $163.2 million in the first quarter
of fiscal 2007. The increase was primarily attributable to the inclusion of
Cytyc revenues for the period from October 22, 2007 (the merger date) to
December 29, 2007, which approximated $158 million. For the first quarter
of fiscal 2008, Hologic reported a net loss of $358.6 million, or $3.31 per
diluted share, compared with net income of $16.1 million, or $0.30 per
diluted share, in the first quarter of fiscal 2007. Included in t
|SOURCE Hologic, Inc.|
Copyright©2008 PR Newswire.
All rights reserved